共 156 条
[1]
Stahl SM(2005)The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants CNS Spectr 10 732-747
[2]
Grady MM(2006)Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry 163 28-40
[3]
Moret C(2002)Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression Biol Psychiatry 52 1166-1174
[4]
Briley M(2002)Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis Br J Psychiatry 180 396-404
[5]
Trivedi MH(2004)Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine J Clin Psychopharmacol 24 389-399
[6]
Rush AJ(2007)Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder J Clin Psychopharmacol 27 672-676
[7]
Wisniewski SR(2007)Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram) Neuropsychobiology 56 73-85
[8]
Nierenberg AA(2005)Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study Depress Anxiety 22 68-76
[9]
Warden D(2006)Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry 163 1905-1917
[10]
Ritz L(2005)Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder Ann Intern Med 143 415-426